6533b870fe1ef96bd12cfc64
RESEARCH PRODUCT
Expression and Signaling of β-Adrenoceptor Subtypes in the Diabetic Heart.
Martin C. MichelBetül R ErdoganEbru Arioglu-inansubject
0301 basic medicineChronotropicCardiac function curveInotropeHeart DiseasesStimulationReview030204 cardiovascular system & hematologyDiabetic heartBioinformaticsβ adrenoceptor03 medical and health sciences0302 clinical medicineDiabetes mellitusReceptors Adrenergic betamedicineDiabetes MellitusEndocrine systemHumansbeta adrenoceptorlcsh:QH301-705.5diabetesbusiness.industryMyocardiumHeartGeneral Medicinemedicine.disease030104 developmental biologylcsh:Biology (General)businessSignal Transductiondescription
Diabetes is a chronic, endocrine disorder that effects millions of people worldwide. Cardiovascular complications are the major cause of diabetes-related morbidity and mortality. Cardiac β1- and β2-adrenoceptor (AR) stimulation mediates positive inotropy and chronotropy, whereas β3-AR mediates negative inotropic effect. Changes in β-AR responsiveness are thought to be an important factor that contributes to the diabetic cardiac dysfunction. Diabetes related changes in β-AR expression, signaling, and β-AR mediated cardiac function have been studied by several investigators for many years. In the present review, we have screened PubMed database to obtain relevant articles on this topic. Our search has ended up with wide range of different findings about the effect of diabetes on β-AR mediated changes both in molecular and functional level. Considering these inconsistent findings, the effect of diabetes on cardiac β-AR still remains to be clarified.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2020-11-26 | Cells |